Archive for the ‘Heart Issues’ Category

Why Are We Accepting Myocarditis as an Acceptable Side Effect for COVID Shots? 2,433 Fetal Deaths: Study Shows Shots Not Safe for Pregnancy. Video Montage of Athletes ‘Dropping like Flies’ Due to Heart Problems After Jab

**UPDATE Feb. 17, 2022**

And this telling video details how myocarditis concerns are growing. Jefferey Jaxen goes through the VAERS data as well.  Coroner states they are dealing with multiple cases.

https://healthimpactnews.com/2021/dr-linda-wastila-why-are-we-accepting-myocarditis-as-an-acceptable-side-effect-for-covid-vaccines/

Dr. Linda Wastila: Why are we Accepting Myocarditis as an Acceptable Side Effect for COVID Vaccine

Nov. 7, 2021

by Brian Shilhavy
Editor, Health Impact News

Our most-read article last week, by far, was the article on Senator Ron Johnson’s Roundtable discussion held in Washington D.C. where doctors, scientists, and COVID-19 vaccine injured victims met to discuss COVID-19 “vaccine” mandates.

The entire recording of this event is over 3.5 hours long, and so I have been watching it and breaking up the speakers into individual videos to make it easier to watch this truly historical event that happened at our nation’s capital last week.

10 of these powerful presentations were published with that article last week, and you can watch them here:

One of the most powerful presentations was given by Dr. Linda Wastila, who is a PhD professor and heads the Department of Pharmaceutical Health Services Research at the University of Maryland. (Source.)

In her initial presentation, which we published last week, Dr. Wastila stated:

We are citizens who have done our civic duty, but when we suffer serious adverse effects, we’re left high and dry by the FDA, the CDC, the NIH and medical professionals.

We are scientists alarmed by the toxic environment in academia and scientific publishing.

We are military leaders concerned about vaccine safety in the armed services.

We are clinicians who want to treat patients harmed by the vaccines but whose practices are limited by our employers and professional boards.

And we are lawyers and patient advocates seeking help for our injured clients and their families.

We are the people you haven’t heard from.

And we have nothing, absolutely nothing to personally gain from being here. Indeed, we have everything to lose, including our jobs, our titles, our livelihoods.

But we don’t intend to go away until we see some real change.

Dr. Wastila later in the meeting gave another presentation about VAERS (Vaccine Adverse Event Reporting System) and the “science of vaccine safety.”

Dr. Wastila is very critical of the CDC for using sound bytes with the public and stating that COVID-19 vaccines are “safe.

The statement that everyone by now has heard come out of the mouth of CDC Director Rochelle Walensky many times, and which is fraudulently printed on the CDC website, is:

Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring in U.S. history.

Dr. Wastila states:

The impression is the system is so finely tuned that even the rarest needle in the haystack will be found.

I am afraid that is just not the case.

Now remember, the reason Senator Johnson invited Dr. Wastila is because drugs and drug safety is her area of expertise.

She states that the process to determine if there are problems that need to be addressed based on reported side effects in VAERS is a very slow process, and she uses myocarditis as an example.

It took four months into Israel’s national vaccine campaign to recognize this side effect. That’s besides the fact that myocarditis generally strikes within days of dosing, particularly the second dose.

So officials were experiencing this side effect for months before officials recognized the vaccine as the cause.

This delay in detecting, researching, and acknowledging side effects is normal.

And it is devastating.

The patients at this meeting today know that devastation first hand.

But it’s also devastating because unless you first recognize harms soon after they occur, you can’t use that knowledge in the next person about to get the vaccine.

I am stunned when I hear people dismiss myocarditis as an acceptable side effect, especially for young people.

Because myocarditis is life-threatening, and a life-disabling condition.

As I reported last week, the CDC admits that myocarditis is caused by COVID-19 vaccines, but they dismiss it as “rare.”

This is what is currently published on the CDC website:

Myocarditis and pericarditis after COVID-19 vaccination are rare. As of October 27, 2021, VAERS has received 1,784 reports of myocarditis or pericarditis among people ages 30 and younger who received COVID-19 vaccine. Most cases have been reported after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna), particularly in male adolescents and young adults. Through follow-up, including medical record reviews, CDC and FDA have confirmed 1,005 reports of myocarditis or pericarditis. CDC and its partners are investigating these reports to assess whether there is a relationship to COVID-19 vaccination.

Why are we continuing to inject children with these shots? Under what possible logic or ethics is 1,784 reports of myocarditis or pericarditis among people under the age of 30 acceptable?

There are far more reports of myocarditis or pericarditis following COVID-19 shots than following ALL vaccines for the past 30+ years recorded in VAERS.

And we know this is only a fraction of the actual cases because VAERS is under-reported, and many of these cases have already led to deaths.

The CDC and FDA have never conducted a study to determine what this under-reported factor is, but independent scientists have, and we have previously published the analysis conducted by Dr. Jessica Rose, who has determined that a conservative under-reported factor would be X41.

That would put the truer picture of young people suffering from myocarditis closer to 74,928 cases, and now they have just begun to inject 5 to 11 year olds.

Watch Dr. Linda Wastila’s presentation. This is our Rumble and Bitchute channels.

______________

Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings

_________________

More Hospitalizations For “Vaccinated” Kids Than From COVID

In Pfizer’s FDA briefing document using unverified and misleading math, they admit there may be more hospitalizations among children for myocarditisthan from COVID.

“Under Scenario 3 (lowest incidence), the model predicts more excess hospitalizations due to vaccine-related myocarditis/pericarditis compared to prevented hospitalizations due to COVID-19 in males and in both sexes combined,” states Pfizer in page 33 of the document.

  • A preprint from University of California Davis found that “for boys 12-15 without medical comorbidities receiving their second mRNA vaccination dose, the rate of CAE [cardiac adverse event ] is 3.7 to 6.1 times higher than their 120-day COVID-19 hospitalization risk as of August 21, 2021″
  • A recent study of the Danish population published in the Pediatric Infectious Disease Journal found that “the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States
  • If you take the 128 reported vaccine deaths among those ages 12-24 as a baseline, and utilize Kirsch, Rose, and Crawford’s estimate that VAERS undercounts fatal reactions by a factor of 41, that would amount to 5,248 deaths
  • There are essentially zero COVID deaths for healthy children
  • More than half of children likely already had COVID
  • There are successful treatments available  Source

______________

https://healthimpactnews.com/2021/2433-dead-babies-in-vaers-as-another-study-shows-mrna-shots-not-safe-for-pregnant-women/  Video Here

2,433 Dead Babies in VAERS as Another Study Shows mRNA Shots Not Safe for Pregnant Women

by Brian Shilhavy
Editor, Health Impact News

Excerpts:

Last month (October, 2021) the New England Journal of Medicine admitted that the original study used to justify the CDC and the FDA in recommending the shots to pregnant women was flawed. (Source.)  Since then, researchers in New Zealand have conducted a new study on the original data, and concluded:

A re-analysis of these figures indicates a cumulative incidence of spontaneous abortion ranging from 82% (104/127) to 91% (104/114), 7–8 times higher than the original authors’ results. (Source.)

And yet, the CDC and FDA still continue to recommend the shots for pregnant women….

Shilhavy points out the fact that Dr. Jessica Rose has given a conservative estimate that VAERS reporting is under-reported by a factor of X41, which means…..

There have probably been at least 99,753 fetal deaths following COVID-19 injections so far.

(See link for article and video of fetal adverse reactions)

_________________

https://www.thegatewaypundit.com/2021/11/12-year-old-child-dies-two-days-taking-pfizer-vaccine-germany-officials-pull-back-mandatory-shots-children/

12-Year-Old Child Dies Two Days After Taking Pfizer Vaccine in Germany – Officials Pull Back on Mandatory Shots for Children

The district of Cuxhaven, Germany confirmed on Wednesday, November 3, 2021, that a 12-year-old child died two days after taking the Pfizer vaccine. Police are investigating and an autopsy was ordered due to the short interval between vaccination and death.  The result of the autopsy is still pending and is expected to be released this week at the earliest.

“The current status of the autopsy suggests a connection,” Kirsten von der Lieth, press spokeswoman for the district said about the vaccine and the child’s death.

(See link for article)

_________________

https://healthimpactnews.com/2021/athletes-around-the-world-are-dropping-like-flies-with-heart-problems/  Video Here

Athletes Around the World are Dropping Like Flies with Heart Problems

by Brian Shilhavy
Editor, Health Impact News

Someone has put together a video montage showing the sheer volume of athletes around the world dropping like flies with heart problems, and the corporate media calls this a “mystery.”  How many people ever heard of the word “myocarditis” prior to the COVID shots?  But don’t blame it on the “vaccines.” That would be politically incorrect.

Mark Payne in the UK is keeping a fast growing list of these stories here.

This is on our Bitchute and Rumble channels.  (Go to link for video)

_________________

https://www.activistpost.com/2021/11/politics-is-a-total-sham-aaron-rodgers-destroys-both-parties-champions-bodily-autonomy-becomes-un-cancelable.  Video Here

Aaron Rodgers Champions Bodily Autonomy

Meanwhile, athletes like Green Bay Packer Aaron Rodgers are crucified for not getting jabbed. It doesn’t matter to critics that he’s allergic to two of the shots and the third one wasn’t available due to being temporarily pulled for clotting issues at the time players were getting vaccinated.

He spoke with doctors and instead chose an immunization protocol that took multiple months to complete.

The article points out that it must have worked as Rodgers looked completely healthy despite having COVID-19.

Best parts of the interview:

How about we teach people how to be healthy?

You have a right to make a decision about your body. That should be an unalienable right for all people to make an educated decision based on what they think is best for them.”  Aaron Rodgers

Rodgers went on to call out the billions in our tax dollars that are flowing into the bank accounts of Big Pharma.

“Let’s move this forward with some love and connection, that’s what we need in this world. Let’s communicate instead of canceling someone or silencing someone. That gets us nowhere.”  Aaron Rodgers

Great points.

Does Lyme Carditis Differ in Children vs. Adults?

https://danielcameronmd.com/lyme-carditis-children-vs-adults/

Does Lyme carditis differ in children vs. adults?

lyme carditis in child being examined by doctor
In their article, “Lyme Carditis in Hospitalized Children and Adults, a Case Series,” Shen and colleagues compare, for the first time, the presentation, management, and outcomes of Lyme carditis in the pediatric versus adult populations.

The authors analyzed charts of pediatric and adult patients with heart block and a positive Western Blot test for Lyme disease, who were hospitalized at Maine Medical Center. The study included 10 children and 20 adults who were admitted for Lyme carditis between January 2010 and December 2018.¹ The children’s mean age was 12.4 years. The adult mean age was 41.4 years.

The case series found:

  • 90% of the Lyme carditis patients were male, with 87% having no prior cardiac history.
  • All cases presented between June and October.
  • Of the 13 cases who noted symptom onset, 76% presented within 3 weeks of illness.
  • Out of 30 patients, 17 were evaluated at an outpatient facility. “Of these, a minority (41%) had Lyme disease suspected in the outpatient setting, and fewer (12%) were initiated on Lyme disease treatment.”

“Improved early recognition and treatment of Lyme disease may decrease Lyme carditis.”

  • Children with Lyme carditis were more likely to present with disseminated erythema migrans and fever. Otherwise, children and adults had similar symptom presentations, exhibiting predominantly presyncope and syncope.
  • “There was no statistical difference between pediatric and adult cases with regards to heart block type or other cardiac complications,” the authors write. “However, the most common heart block in pediatric cases was first-degree (40%) vs second-degree Mobitz type 2 in adult cases (55%).”
  • Adults were more likely to require a pacemaker (60%) compared with 20% of children. “Proportionately more adults needed temporary pacing,” the authors write, while “Children had shorter antibiotic durations…”

“… there is room for improving outpatient diagnosis and treatment of early Lyme disease, even in a high-incidence state like Maine.”

  • Out of the 30 cases, 27 had improved heart block, while 3 adults required a pacemaker at discharge. One patient died.

The authors point out that the majority of these cases were evaluated by an outpatient provider before carditis developed. However, only 41% of the patients were diagnosed with or suspected to have Lyme disease at that visit.

Furthermore, even fewer (12%) of those patients received appropriate antibiotics.

“Overall, there were no major differences seen between the presentations or outcomes of pediatric and adult Lyme carditis cases,” the authors write.

“Earlier diagnosis and treatment would likely have prevented carditis and the need for hospital admission,” the authors conclude.

“… there is room for improving outpatient diagnosis and treatment of early Lyme disease, even in a high-incidence state like Maine.”

Study: Pfizer Vaccine Increases Myocarditis Threefold & Chinese Cupping Shows Why

**UPDATE Feb. 17. 2022**

And this telling video details how myocarditis concerns are growing. Jefferey Jaxen goes through the VAERS data as well.  Coroner states they are dealing with multiple cases.

https://articles.mercola.com/sites/articles/archive/2021/09/21/pfizer-covid-vaccine-increases-myocarditis-threefold

Study: Pfizer Vaccine Increases Myocarditis Threefold

Analysis by Dr. Joseph Mercola Fact Checked
pfizer covid vaccine increases myocarditis threefold

Story at-a-glance

  • A large study from Israel revealed that the Pfizer COVID-19 mRNA jab is associated with a threefold increased risk of myocarditis, leading to the condition at a rate of one to five events per 100,000 persons
  • Other elevated risks were also identified following the COVID jab, including lymphadenopathy (swollen lymph nodes), appendicitis and herpes zoster infection
  • When myocarditis occurs, it reduces your heart’s ability to pump and can cause rapid or abnormal heart rhythms that can be deadly
  • In severe cases, myocarditis can cause permanent damage to the heart muscle and lead to heart failure, heart attack, stroke and sudden cardiac death; in August 2021, New Zealand reported the death of a woman following Pfizer’s COVID-19 jab, which they believe was due to vaccine-induced myocarditis
  • Due to the risk of myocarditis, Britain’s Joint Committee on Vaccination and Immunization (JCVI) recommended against COVID-9 injections for healthy 12- to 15-year-olds

As the mass administration of COVID-19 jabs continue worldwide, we’re beginning to see some of the more common side effects emerging. Myocarditis, or inflammation of the heart muscle, is among them. This condition can cause symptoms similar to a heart attack, including chest pain, shortness of breath, abnormal heartbeat and fatigue.1

A large study from Israel2 revealed that the Pfizer COVID-19 mRNA jab is associated with a threefold increased risk of myocarditis,3 leading to the condition at a rate of one to five excess events per 100,000 persons.4 Other elevated risks were also identified following the COVID jab, including lymphadenopathy (swollen lymph nodes), appendicitis and herpes zoster infection.5

Pfizer COVID Jab Poses Risk to the Heart

The real-world case-control study from Israel included a mean of 884,828 people aged 16 years and older in each of two groups: one vaccinated and one control.6 The increased risk of myocarditis was clear, with researchers noting:7

The risk appears to be highest among young men. We found that the risk of myocarditis increased by a factor of three after vaccination, which translated to approximately 3 excess events per 100,000 persons; the 95% confidence interval indicated that values between 1 and 5 excess events per 100,000 persons were compatible with our data.

Among the 21 persons with myocarditis in the vaccinated group, the median age was 25 years (interquartile range, 20 to 34), and 90.9% were male.”

When myocarditis occurs, it reduces your heart’s ability to pump and can cause rapid or abnormal heart rhythms that can be deadly. In severe cases, myocarditis can cause permanent damage to the heart muscle and lead to heart failure, heart attack, stroke and sudden cardiac death.8 In August 2021, New Zealand reported the death of a woman following Pfizer’s COVID-19 jab, which they believe was due to vaccine-induced myocarditis.9

The death prompted the Ministry of Health to issue a statement to ensure “health care professionals and consumers remain vigilant and are aware of the signs of myocarditis and pericarditis” following the jab.10

A number of studies have now found a connection between COVID-19 jabs and myocarditis. In a September-October 2021 case report with literature review, it was concluded that “the outcomes of this case scenario confirm myocarditis as a probable complication of COVID-19 vaccines.”11 Another study from Israel detailed myocarditis following Pfizer’s COVID-19 jab in six male patients with a median age of 23 years.12

A similar study published in Pediatrics13 reported seven cases of acute myocarditis or myopericarditis in otherwise healthy adolescent males. Each had experienced chest pain within four days of receiving the second dose of Pfizer’s COVID-19 jab. Data published in JAMA Cardiology14 by physicians from the Navy, Army and Air Force also revealed a higher-than-expected rate of myocarditis in U.S. military personnel who received a COVID-19 jab.

Dr. Charles Hoffe, a family physician from Lytton, British Columbia, told health officials that his patients were suffering adverse effects from the mRNA COVID-19 vaccines, including myocarditis.15 About his young, male patients, Hoffe explained, “They have permanently damaged hearts.”:16

“It doesn’t matter how mild it is, they will not be able to do what they used to do because heart muscle doesn’t regenerate. The long-term outlook is very grim, and with each successive shot, it will add more damage. The damage is cumulative because you’re progressively getting more damaged capillaries.”

Officials Advise Against Vaccination of 12- to 15-Year-Olds

Due to the risk of myocarditis, Britain’s Joint Committee on Vaccination and Immunization (JCVI) recommended against COVID-9 injections for healthy 12- to 15-year-olds. JCVI member Adam Finn told Reuters:17

“… the number of serious cases that we see of COVID in children this age are really very small. There are uncertainties about the long-term implications of (myocarditis), and that makes the risk-benefit balance for these children really quite tight and much tighter than we would be comfortable to make the recommendation.”

In the U.S., the Centers for Disease Control and Prevention (CDC) is also investigating myocarditis and pericarditis, which is inflammation of the outer lining of the heart, following mRNA COVID-19 jabs, stating that more than 1,000 cases have been reported to the Vaccine Adverse Event Reporting System (VAERS) since April 2021.18 According to the CDC:19

“As of August 25, 2021, VAERS has received 1,377 reports of myocarditis or pericarditis among people ages 30 and younger who received COVID-19 vaccine …

Most cases have been reported after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna), particularly in male adolescents and young adults. Through follow-up, including medical record reviews, CDC and FDA have confirmed 798 reports of myocarditis or pericarditis. CDC and its partners are investigating these reports to assess whether there is a relationship to COVID-19 vaccination.”

Despite the risk, the CDC is still advising children aged 12 and older to get the jab, and August 23, 2021, the U.S. Food and Drug Administration granted full approval to Pfizer’s COVID-19 mRNA injection, now sold under the brand name Comirnaty, for people aged 16 and older.20

FDA Lists Myocarditis on Jab’s Prescribing Information

The injection’s approval represents the fastest approval in history,21 granted less than four months after Pfizer filed for licensing May 7, 2021.22 It’s also based on only up to six months’ worth of data from 44,060 people aged 16 and older.23,24 Half of them got the shots and half initially received a placebo.

However, in the second week of December 2020, Pfizer unblinded the control group and 93% of controls opted to get the real injection rather than remain in the control group for the remainder of the trial, which is slated to continue for another two years. In their prescribing information, the risk of heart inflammation is acknowledged. As reported by STAT News:25

“The FDA’s prescribing information for the vaccine includes its associated risk of myocarditis and pericarditis, two types of heart inflammation that have appeared rarely among people who’ve received the mRNA vaccines, mostly within seven days after the second shot, health officials said.

Men under 40 appear to be at higher risk than women and older men, with the highest observed risk in boys age 12 to 17.”

Further, in its approval letter for Comirnaty, the FDA orders Pfizer to conduct research to investigate the risk of inflammation in and around the heart, as voluntary reporting mechanisms are insufficient.26

The FDA accepted Pfizer’s suggested timetable for the post-approval study to evaluate incidence of heart and heart sack inflammation, which includes the submission of an interim report at the end of October 2023, a study completion date of June 30, 2025, and submission of a final report October 31, 2025.

Spike Protein in the Jab Is Inflammatory

Dr. Robert Malone, the inventor of the mRNA and DNA vaccine core platform technology,27 has been bravely warning of the dangers of COVID-19 jabs, in part due to the spike protein they contain.

In its native form in SARS-CoV-2, the spike protein is responsible for the pathologies of the viral infection, and in its wild form it’s known to open the blood-brain barrier, cause cell damage (cytotoxicity) and, Malone said, “is active in manipulating the biology of the cells that coat the inside of your blood vessels — vascular endothelial cells, in part through its interaction with ACE2, which controls contraction in the blood vessels, blood pressure and other things.”28

Malone is well aware of the actions of spike protein, as he worked to identify an effective drug that worked by blocking the action of the COX-2 enzyme, which is a key inflammatory enzyme. In one of his papers, he laid out how the spike protein and another protein in the virus directly turn on COX-2 promoter in infected cells.

This awareness of the spike protein as a biologically active protein made him alert the FDA in fall 2020 about the associated risks. His FDA colleagues transferred his concerns to the FDA’s review branch, which dismissed his concerns, saying they did not believe the spike protein was biologically active and there wasn’t enough documentation otherwise. As history now reveals, they proceeded with the EUA.

It’s since been revealed, however, that the spike protein on its own is enough to cause inflammation and damage to the vascular system, even independent of a virus.29 Blood clots are another serious concern related to the spike protein. According to Hoffe:30

“[It] becomes part of the cell wall of your vascular endothelium, which means that these cells, which line your blood vessels, which are supposed to be smooth so that your blood flows smoothly now have these little spiky bits sticking out.

So it is absolutely inevitable that blood clots will form, because your blood platelets circulate around in your vessels and the purpose of blood platelets is to detect a damaged vessel and block that damage when it starts bleeding.

So when a platelet comes through a capillary and suddenly hits all these covid spikes that are jutting into the inside vessel … blood clots will form to block that vessel. That’s how platelets work.”

Hoffe has been conducting the D-dimer test on his patients within four to seven days of them receiving a COVID-19 injection and found that 62% have evidence of clotting.31

Because of the risk of the formation of blood clots in your vessels, Dr. Sucharit Bhakdi,32 a retired professor, microbiologist and infectious disease and immunology specialist who, along with several other doctors and scientists, formed Doctors for COVID Ethics, went so far as to say that giving the COVID-19 injection to children is a crime: “Do not give it to children because they have absolutely no possibility to defend themselves, if you give it to your child you are committing a crime.”

As mentioned, due to myocarditis risks in youth, Great Britain’s JCVI is also taking a precautionary approach for COVID-19 injections among 12- to 15-year-olds. Wei Shen Lim, COVID-19 chair for JCVI, stated, “The margin of benefit is considered too small to support universal Covid-19 vaccination for this age group at this time.”33

___________________

https://www.brighteon.com/f56e9e0a-205e-46c8-8cc9-759c0ff456f5  Video Here (Approx. 2 Min)

Chinese Cupping “Vaccinated” Blood Shows it Becomes JELLY

Health Ranger Report

Sept. 23, 2021

This certainly explains all the blood abnormalities, blood clotting, and heart issues being experienced after the shots.

For more:

Vaccine-Induced Thrombocytopenia With Severe Headache – Why Lyme/MSIDS Patients Should Care

https://www.nejm.org/doi/full/10.1056/NEJMc2112974?

Vaccine-Induced Thrombocytopenia with Severe Headache

To the Editor:

Vaccine-induced immune thrombotic thrombocytopenia (VITT), a serious adverse event after vaccination with ChAdOx1 nCoV-19 (AstraZeneca) or Ad26.COV2.S (Johnson & Johnson–Janssen), is caused by platelet factor 4 (PF4)–dependent, platelet-activating antibodies.1-3 High-dose immune globulins and anticoagulation are the main treatments.4,5 In this report, we present evidence that vaccine-induced thrombocytopenia (VIT) without associated cerebral venous sinus thrombosis (CVST) or other thromboses and with severe headache as the heraldic symptom may precede VITT (“pre-VITT syndrome”).

Eleven patients presented with severe headache in the absence of CVST 5 to 18 days after ChAdOx1 nCoV-19 vaccination.

  • All the patients had thrombocytopenia (low platelets in the blood which can cause hemorrhaging)
  • high d-dimer levels (a test to detect blood clots – a high level indicates clot formation and breakdown in the body)
  • high levels of anti–PF4–heparin IgG antibodies
  • during follow-up, intracranial hemorrhage occurred in three patients (Patients 1, 2, and 3), with radiologic evidence of new CVST in Patients 2 and 3 (Figure 1, and Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org).
  • Only two patients (Patients 2 and 4) were initially admitted with conditions that met the criteria for VITT; both patients had pulmonary embolism, and additional splanchnic vein thrombosis was present in Patient 2.

In Patient 2, anticoagulation treatment had been initiated several days earlier for pulmonary embolism (without diagnosis of VITT) but was stopped after the onset of headache, shortly before CVST developed.

  • In two patients (Patients 1 and 3), peripheral thromboses were eventually identified during follow-up.

Thrombotic complications did not develop in seven of the patients (Patients 5 through 11); all but one of these patients received high-dose immune globulin, glucocorticoids, or therapeutic-dose anticoagulation within 5 days after headache onset. In contrast, in all four patients with subsequent thrombosis (Patients 1 through 4), therapeutic-dose anticoagulation either was not started until 6 to 9 days after headache onset or was stopped prematurely before the development of CVST.

Although the combination of thrombocytopenia and severe headache due to CVST has been recognized as the typical presentation of VITT,1,2 the experience with these 11 patients suggests that VIT with severe headache, elevated d-dimer levels, and strongly positive results on anti–PF4–heparin IgG enzyme-linked immunosorbent assay may precede VITT.

Our findings have immediate implications for clinical practice: in this pre-VITT syndrome, severe headache may not develop as a symptom secondary to CVST but instead may precede CVST by several days, potentially in association with microthrombosis in smaller cortical veins.

Consequently, patients who present with severe headache 5 to 20 days after adenovirus vector vaccination against coronavirus disease 2019 should undergo immediate testing for thrombocytopenia and d-dimer levels and, if available, testing for anti–PF4–heparin IgG antibodies.

When these antibodies are present at high titers, patients are at imminent risk for CVST, and it is likely that this condition can be prevented with immediate treatment, such as with intravenous immune globulin. The decision to initiate therapeutic-dose anticoagulation is a difficult one; the risk of emerging thrombosis, including CVST, has to be balanced against the risk of intracranial hemorrhage on an individual basis (e.g., with consideration of platelet count and fibrinogen levels).

Farid Salih, M.D.
Charité-Universitätsmedizin Berlin, Berlin, Germany

Linda Schönborn, M.D.
Universitätsmedizin Greifswald, Greifswald, Germany

Siegfried Kohler, M.D., Christiana Franke, M.D., Martin Möckel, M.D., Thomas Dörner, M.D., Hans C. Bauknecht, M.D., Christian Pille, M.D., Jan A. Graw, M.D.
Charité-Universitätsmedizin Berlin, Berlin, Germany

Angelika Alonso, M.D.
University Hospital of Mannheim, Mannheim, Germany

Johann Pelz, M.D.
University Hospital of Leipzig, Leipzig, Germany

Hauke Schneider, M.D., Antonios Bayas, M.D., Monika Christ, M.D.
University Hospital of Augsburg, Augsburg, Germany

Joji B. Kuramatsu, M.D.
University Hospital of Erlangen, Erlangen, Germany

Thomas Thiele, M.D., Andreas Greinacher, M.D.
Universitätsmedizin Greifswald, Greifswald, Germany

Matthias Endres, M.D.
Charité-Universitätsmedizin Berlin, Berlin, Germany

Supported by Deutsche Forschungsgemeinschaft project number 374031971–TRR 240 (to Prof. Greinacher) and EXC-2049–390688087 NeuroCure under the German Excellence Strategy (to Prof. Endres) and by the Domagk-Programm of the Universitätsmedizin Greifswald (to Dr. Schönborn).

Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.

This letter was published on September 15, 2021, at NEJM.org.

Profs. Greinacher and Endres contributed equally to this letter.

___________________

**Comment**

Both Thrombocytopenia and severe headaches are common with Lyme/MSIDS patients.

Therapy for thrombocytopenia requires treatment or removal of the underlying infection, in addition to maintenance of platelet counts and hemostatic function.

Hopefully it’s clear that a Lyme/MSIDS patient getting a COVID shot could be diagnosed with thrombocytopenia that either already exists or worsens after the injection.  Treating the underlying infection is imperative but won’t be considered by mainstream medicine.

For more:

Go here for the latest VAERS data and the mounting list of adverse reactions and deaths.

Myocarditis After COVID-19 mRNA Shots But Just Mask Up & Shut Up

https://www.nejm.org/doi/full/10.1056/NEJMc2109975?

Myocarditis after Covid-19 mRNA Vaccination

This letter was published on August 18, 2021, at NEJM.org.

TO THE EDITOR:

The Centers for Disease Control and Prevention recently reported cases of myocarditis and pericarditis in the United States after coronavirus disease 2019 (Covid-19) messenger RNA (mRNA) vaccination.1 In recently published reports, diagnosis of myocarditis was made with the use of noninvasive imaging and routine laboratory testing.2-5 Here, we report two cases of histologically confirmed myocarditis after Covid-19 mRNA vaccination.

Figure 1. Histopathological Findings from Endomyocardial Biopsy and Autopsy.

Patient 1, a 45-year-old woman without a viral prodrome, presented with dyspnea and dizziness 10 days after BNT162b2 vaccination (first dose). A nasopharyngeal viral panel was negative for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A and B, enteroviruses, and adenovirus (Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org). A serum polymerase-chain-reaction (PCR) assay and serologic tests showed no evidence of active parvovirus, enterovirus, human immunodeficiency virus, or infection with SARS-CoV-2. At presentation, she had tachycardia; ST-segment depression detected on electrocardiography, which was most prominent in the lateral leads (Fig. S1); and a troponin I level of 6.14 ng per milliliter (reference range, 0 to 0.30). A transthoracic echocardiogram showed severe global left ventricular systolic dysfunction (ejection fraction, 15 to 20%) and normal left ventricular dimensions. Right heart catheterization revealed elevated right- and left-sided filling pressures and a cardiac index of 1.66 liters per minute per square meter of body-surface area as measured by the Fick method. Coronary angiography revealed no obstructive coronary artery disease. An endomyocardial biopsy specimen showed an inflammatory infiltrate predominantly composed of T-cells and macrophages, admixed with eosinophils, B cells, and plasma cells (Figure 1A and Figs. S2 through S4). She received inotropic support, intravenous diuretics, methylprednisolone (1 g daily for 3 days), and, eventually, guideline-directed medical therapy for heart failure (lisinopril, spironolactone, and metoprolol succinate). Seven days after presentation, her ejection fraction was 60%, and she was discharged home.

Patient 2, a 42-year-old man, presented with dyspnea and chest pain 2 weeks after mRNA-1273 vaccination (second dose). He did not report a viral prodrome, and a PCR test was negative for SARS-CoV-2 (Table S1). He had tachycardia and a fever, and his electrocardiogram showed diffuse ST-segment elevation (Fig. S1). A transthoracic echocardiogram showed global biventricular dysfunction (ejection fraction, 15%), normal ventricular dimensions, and left ventricular hypertrophy. Coronary angiography revealed no coronary artery disease. Cardiogenic shock developed in the patient, and he died 3 days after presentation. An autopsy revealed biventricular myocarditis (Figure 1B and Figs. S5 and S6). An inflammatory infiltrate admixed with macrophages, T-cells, eosinophils, and B cells was observed, a finding similar to that in Patient 1.

In these two adult cases of histologically confirmed, fulminant myocarditis that had developed within 2 weeks after Covid-19 vaccination, a direct causal relationship cannot be definitively established because we did not perform testing for viral genomes or autoantibodies in the tissue specimens. However, no other causes were identified by PCR assay or serologic examination.

Amanda K. Verma, M.D.
Kory J. Lavine, M.D., Ph.D.
Chieh-Yu Lin, M.D., Ph.D.
Washington University School of Medicine, St. Louis, MO

________________________

https://www.brighteon.com/b3d87a5a-faea-4341-bab6-0406b9d356f5  4 Min. Video Here

The HighWire with Del Bigtree
Published Aug. 16, 2021

‘MASK UP AND SHUT UP’

Entering the ridiculous, public health officials are now asking people not to talk to stop the Covid virus. Jefferey Jaxen dives into the science behind the latest Covid mitigation suggestion.

__________________

**Comment**

The video is revealing on many fronts:

  • Propaganda is alive and well.
  • The paper “Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted By COVID-19 Patients While Breathing, Talking, and Singing,” has numerous disclaimers in fine print, namely, that they couldn’t mechanically retrieve and isolate a viable virus from ambient air in the vicinity of patients.  Well, that’s inconvenient.
  • This study demonstrates perfectly the hypocrisy of our corrupt public health ‘authorities’ in that they demand perfectly done randomized, controlled trials on thousands of patients to approve COVID treatments, completely ignoring clinical results, but will accept and propagate poorly done science that pushes their continued fear narrative that lines their pockets. And even when there properly done RCTs they ignore them and then go on a smear campaign to malign them, and implement bandwagon to make the public believe their accepted narrative.
  • This duplicity has been going on in Lyme-land for over 40 years and continues today.  Hopefully people are waking up to it.